Skip to content

The Comparative Study of Diazepam with Two Different Doses in Prevention of Febrile Seizure Recurrence and its Complications in Children Aged 6 Months to 6 Years Old

The Comparative Study of Diazepam with Two Different Doses in Prevention of Febrile Seizure Recurrence and its Complications in Children Aged 6 Months to 6 Years Old

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014102719700N1
Enrollment
280
Registered
2015-02-14
Start date
2012-09-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Febrile Seizure. Febrile convulsions

Interventions

Intervention 1: Intervention group: Diazepam, dose: 0.3 mg for each kg of body weight, frequency of use: 3, duration: 8 hours. Intervention 2: Intervention group: Diazepam, dose: 0.3 mg for each kg of
Prevention
Intervention group: Diazepam, dose: 0.3 mg for each kg of body weight, frequency of use: 3, duration: 8 hours
Intervention group: Diazepam, dose: 0.3 mg for each kg of body weight, frequency of use: 2, duration: 12 hours

Sponsors

Vice Chancellor for Research Golestan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Months to 5 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patient who do not have generalized seizure and a focal sign and Seizure prolong more than 15 minute and seizure more than 1 time in a day; Abnormal neurological function abnormal neurological examination and development disorder; Progressive neurological disease; Seizure due to central nerves system infection. Exclusion criteria: Seizure for other reasons is not FC (epilepsy (epilepsy, electrolyte disorders, trauma, etc.); The presence of abnormal EEG.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Febrile Seizure. Timepoint: one year. Method of measurement: questionnaire.

Secondary

MeasureTime frame
Side effects. Timepoint: one year. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShima Shekari

Golestan University of Medical Sciences

shekari61@guoms.ac.ir+98 173243310

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026